Cargando…
Surgical Options for Initially Unresectable Colorectal Liver Metastases
Although the frontiers of liver resection for colorectal liver metastases have broadened in recent decades, approximately 75% of these patients present with unresectable metastases at the time of their diagnosis. In the past, these patients underwent only palliative treatment, without the chance of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469091/ https://www.ncbi.nlm.nih.gov/pubmed/23082042 http://dx.doi.org/10.1155/2012/454026 |
_version_ | 1782246035045744640 |
---|---|
author | Popescu, Irinel Alexandrescu, Sorin Tiberiu |
author_facet | Popescu, Irinel Alexandrescu, Sorin Tiberiu |
author_sort | Popescu, Irinel |
collection | PubMed |
description | Although the frontiers of liver resection for colorectal liver metastases have broadened in recent decades, approximately 75% of these patients present with unresectable metastases at the time of their diagnosis. In the past, these patients underwent only palliative treatment, without the chance of a cure. In the previous two decades, several therapeutic strategies have been developed that render resectable those metastases that were initially unresectable, thus offering the chance of long-term survival and even a cure to these patients. The oncosurgical modalities that are available include liver resection following portal vein ligation/embolization, “two-stage” liver resection, one-stage ultrasonically guided liver resection, hepatectomy following conversion chemotherapy, and liver resection combined with thermal ablation. Moreover, in recent years, certain authors have recommended the revisiting of the concept of liver transplantation in highly selected patients with unresectable colorectal liver metastases and favorable prognostic factors. By employing such therapies, the number of patients with colorectal liver metastases who undergo a potentially curative treatment could increase to 40%. The safety profile of these approaches is acceptable (morbidity rates as high as 45%, mortality rates of less than 5%). Furthermore, the 5-year survival rates (approximately 30%) are significantly increased over those that were achieved with palliative treatment. |
format | Online Article Text |
id | pubmed-3469091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34690912012-10-18 Surgical Options for Initially Unresectable Colorectal Liver Metastases Popescu, Irinel Alexandrescu, Sorin Tiberiu HPB Surg Review Article Although the frontiers of liver resection for colorectal liver metastases have broadened in recent decades, approximately 75% of these patients present with unresectable metastases at the time of their diagnosis. In the past, these patients underwent only palliative treatment, without the chance of a cure. In the previous two decades, several therapeutic strategies have been developed that render resectable those metastases that were initially unresectable, thus offering the chance of long-term survival and even a cure to these patients. The oncosurgical modalities that are available include liver resection following portal vein ligation/embolization, “two-stage” liver resection, one-stage ultrasonically guided liver resection, hepatectomy following conversion chemotherapy, and liver resection combined with thermal ablation. Moreover, in recent years, certain authors have recommended the revisiting of the concept of liver transplantation in highly selected patients with unresectable colorectal liver metastases and favorable prognostic factors. By employing such therapies, the number of patients with colorectal liver metastases who undergo a potentially curative treatment could increase to 40%. The safety profile of these approaches is acceptable (morbidity rates as high as 45%, mortality rates of less than 5%). Furthermore, the 5-year survival rates (approximately 30%) are significantly increased over those that were achieved with palliative treatment. Hindawi Publishing Corporation 2012 2012-10-03 /pmc/articles/PMC3469091/ /pubmed/23082042 http://dx.doi.org/10.1155/2012/454026 Text en Copyright © 2012 I. Popescu and S. T. Alexandrescu. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Popescu, Irinel Alexandrescu, Sorin Tiberiu Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title | Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title_full | Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title_fullStr | Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title_full_unstemmed | Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title_short | Surgical Options for Initially Unresectable Colorectal Liver Metastases |
title_sort | surgical options for initially unresectable colorectal liver metastases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469091/ https://www.ncbi.nlm.nih.gov/pubmed/23082042 http://dx.doi.org/10.1155/2012/454026 |
work_keys_str_mv | AT popescuirinel surgicaloptionsforinitiallyunresectablecolorectallivermetastases AT alexandrescusorintiberiu surgicaloptionsforinitiallyunresectablecolorectallivermetastases |